Hart, R. G., Sharma, M., Mundl, H., Kasner, S. E., Bangdiwala, S. I., Berkowitz, S. D., . . . Connolly, S. J. (2018). Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. The New England journal of medicine, 378(23), 2191-2201. https://doi.org/10.1056/NEJMoa1802686
Citácia podle Chicago (17th ed.)Hart, Robert G., et al. "Rivaroxaban for Stroke Prevention After Embolic Stroke of Undetermined Source." The New England Journal of Medicine 378, no. 23 (2018): 2191-2201. https://doi.org/10.1056/NEJMoa1802686.
Citácia podľa MLA (8th ed.)Hart, Robert G., et al. "Rivaroxaban for Stroke Prevention After Embolic Stroke of Undetermined Source." The New England Journal of Medicine, vol. 378, no. 23, 2018, pp. 2191-2201, https://doi.org/10.1056/NEJMoa1802686.